These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17630410)

  • 21. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FPIN's clinical inquiries: brain natriuretic peptide for ruling out heart failure.
    Cullan A; Grover M; Hitchcock K
    Am Fam Physician; 2011 Jun; 83(11):1333-4. PubMed ID: 21661716
    [No Abstract]   [Full Text] [Related]  

  • 25. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?
    van Kimmenade RR; Pinto Y; Januzzi JL
    Eur Heart J; 2007 Dec; 28(24):2960-1. PubMed ID: 17984131
    [No Abstract]   [Full Text] [Related]  

  • 27. [The diagnostic value of N-terminal probrainnatriuretic peptide in patients with dyspnea].
    Zhu Y; Cai B; Wang LL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):458-60. PubMed ID: 18575341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide - a biomarker for all seasons?
    Mark DB; Felker GM
    N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
    [No Abstract]   [Full Text] [Related]  

  • 30. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
    Lamb EJ; Vickery S; Price CP
    J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
    Baggish AL; van Kimmenade RR; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
    Daly MG; Frampton CM; Troughton RW
    J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
    [No Abstract]   [Full Text] [Related]  

  • 35. Natriuretic peptide testing in heart failure.
    Kim HN; Januzzi JL
    Circulation; 2011 May; 123(18):2015-9. PubMed ID: 21555724
    [No Abstract]   [Full Text] [Related]  

  • 36. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath].
    Bayés-Genís A
    Rev Esp Cardiol; 2005 Oct; 58(10):1142-4. PubMed ID: 16238980
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptide: a universal cardiac biomarker?
    Teodorovich N; Krakover R; Vered Z
    Isr Med Assoc J; 2008 Feb; 10(2):152-3. PubMed ID: 18432033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.